Clinical Trials Directory

Trials / Completed

CompletedNCT03826472

Almond Butter and Fasting Glucose

Almond Butter and Fasting Glucose in Adults With Type 2 Diabetes

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.

Detailed description

Control of fasting blood glucose is a challenge for many individuals with diabetes. Researchers want to better understand how a nighttime snack can affect morning fasting blood glucose. A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 1 week. During the almond butter treatment, participants will consume 2 tbsp of almond butter per day as an evening snack. The control treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take simple cognitive tests on a study-provided smartphone each day of the study and report their daily food intake and physical activity.

Conditions

Interventions

TypeNameDescription
OTHERAlmond ButterNatural almond butter

Timeline

Start date
2019-03-08
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2019-02-01
Last updated
2024-04-09
Results posted
2023-11-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03826472. Inclusion in this directory is not an endorsement.